Associate Director, Pulmonary Vascular Disease Program
110 S. Paca St., 2nd Floor
(410) 328-7260 (For Redwood inquiries)
(410) 328-8141 (For Midtown & other inquiries)
Education and Training
- BS, University of Pittsburgh, Pittsburgh, PA
- MD, University of Maryland School of Medicine, Baltimore, MD
- Residency, Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
- Fellowship, Pulmonary & Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD
My focus is on pulmonary hypertension, a type of high blood pressure that affects the lungs and the right side of the heart. I became interested in pulmonary hypertension because of the complexity in which the heart and lung interact with one another and the continual advances in both therapies and diagnosis being made year after year in the field.
Because of my background in pulmonary medicine, I have a particular focus in patients with pulmonary hypertension due to chronic lung diseases, such as interstitial lung disease, chronic obstructive pulmonary disease (COPD), and sarcoidosis.
The pulmonary hypertension program at the University of Maryland is a well-established PHA-certified program that has offered excellent care for many years. As a pulmonologist, I have been very excited to join this program as it to help offer a comprehensive approach to the treatment of complex disorders that involve both the heart and the lung.
As the patient is at the very center of our care, I strive to fully explain my diagnoses and treatment plans to make sure that patients can be active participants in their own care, especially with such a complex disease. I practice with careful attention to the constantly updating science that is emerging about pulmonary hypertension and its treatment.
Cassady SJ, Reed RM. Pulmonary Hypertension in COPD: A Case & Review of the Literature. Medicina, 2 Aug 2019, 55(8):432.
Cassady SJ, Ramani GV. Right heart failure in pulmonary hypertension. Cardiol Clin 2020 May, 38(2):243-255.
Ramani GV, Shen E, Cassady SJ, Broderick M, Wasik A, Rao Y, Nelsen A. Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on 6-minute walk distance and hospitalizations. Pulm Circ. E-published 16 April 2020.
Cassady SJ, Lasso-Pirot A, Deepak J. Phenotypes of bronchopulmonary dysplasia in adults. CHEST E-published 6 May
Cassady SJ, Mills-Robertson K, Deepak J, Hossain R. CT Angiography-Based Pulmonary Artery Volumetry as a Diagnostic Tool for Pulmonary Hypertension. Journal of Computer-Assisted Tomography Sep/Oct 2020, 44(5):681-686.